IBM (IBM) to Release Earnings on Wednesday

IBM (NYSE:IBM) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, July 17th. Analysts expect IBM to post earnings of $3.06 per share for the quarter.

IBM (NYSE:IBM) last announced its quarterly earnings data on Tuesday, April 16th. The technology company reported $2.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.22 by $0.03. IBM had a return on equity of 68.76% and a net margin of 10.98%. The firm had revenue of $18.18 billion for the quarter, compared to analyst estimates of $18.53 billion. During the same quarter in the prior year, the company posted $2.45 earnings per share. IBM’s quarterly revenue was down 4.7% on a year-over-year basis. On average, analysts expect IBM to post $14 EPS for the current fiscal year and $14 EPS for the next fiscal year.

Shares of IBM stock opened at $143.32 on Tuesday. The business’s fifty day simple moving average is $136.57. IBM has a 1-year low of $105.94 and a 1-year high of $154.36. The firm has a market capitalization of $127.07 billion, a price-to-earnings ratio of 10.38, a PEG ratio of 2.59 and a beta of 1.25. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.36 and a quick ratio of 1.31.

In other IBM news, SVP Kenneth M. Keverian sold 2,690 shares of the company’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $135.50, for a total value of $364,495.00. Following the sale, the senior vice president now owns 34,665 shares of the company’s stock, valued at $4,697,107.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kenneth M. Keverian sold 2,227 shares of the company’s stock in a transaction on Friday, June 14th. The shares were sold at an average price of $135.15, for a total value of $300,979.05. Following the completion of the sale, the senior vice president now directly owns 32,878 shares in the company, valued at approximately $4,443,461.70. The disclosure for this sale can be found here. Insiders sold 7,000 shares of company stock worth $940,430 in the last three months. 0.19% of the stock is owned by corporate insiders.

A number of research analysts recently weighed in on the company. Zacks Investment Research lowered HANNOVER RUECK/S from a “hold” rating to a “sell” rating in a report on Monday, April 22nd. UBS Group set a $160.00 price objective on IBM and gave the stock a “buy” rating in a report on Wednesday, April 17th. Evercore ISI assumed coverage on Sensata Technologies in a report on Wednesday, June 5th. They set an “in-line” rating and a $50.00 price objective on the stock. Credit Suisse Group upped their price objective on Delta Air Lines from $37.00 to $68.00 and gave the stock an “outperform” rating in a report on Thursday, April 11th. Finally, Citigroup dropped their price objective on UnitedHealth Group from $288.00 to $247.00 and set a “neutral” rating on the stock in a report on Wednesday, April 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and seven have given a buy rating to the stock. IBM has a consensus rating of “Hold” and a consensus price target of $155.17.

IBM Company Profile

International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.

Recommended Story: Index Funds

Earnings History for IBM (NYSE:IBM)

Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with's FREE daily email newsletter.